首页 > 市场调查报告书 > 医疗设备

手术用器具

市场调查报告书

商品编码

1606510

全球手持式微创手术器材市场 - 2024-2031

Global Handheld Minimally Invasive Surgical Instruments Market - 2024-2031

出版日期: 2024年12月04日 | 出版商:

DataM Intelligence | 英文 197 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

概述

2023年，全球手持式微创手术器械市场规模达70.9亿美元，预计2031年将达到156.4亿美元，2024-2031年预测期间复合年增长率为10.4%。

手持式微创手术器械是指设计用于微创手术的一类手术工具，与传统开放性手术相比，在体内形成的切口较小。这些器械经过专门设计，可促进精确、受控和高效的手术，对周围组织的创伤最小，从而缩短患者的恢復时间、降低感染风险并减少疤痕。这些器械通常比传统手术工具更小、更轻且设计更符合人体工学。它们紧凑的尺寸使它们能够穿过较小的切口（通常小至几毫米），而不会对周围组织造成重大损伤。

在手术技术进步、对微创手术的日益偏好以及以患者为中心的护理的推动下，手持式微创手术器械市场正在经历强劲增长。随着手术数量的增加，全球对这些器械的需求预计将持续成长。例如，根据萨斯喀彻温省政府的数据，2023年4月1日至2024年3月31日期间进行了超过95,700例手术，这是有记录以来的最高年度手术量。

市场动态：

驱动程式和限制

微创手术的需求不断增加

对微创手术的需求不断增长，极大地推动了手持式微创手术器械市场的成长，预计将在预测期内推动市场成长。微创手术具有切口更小、失血量更少、恢復更快和併发症更少的特点，正在获得患者和医疗保健提供者的广泛采用。手术实践的这种转变增加了对先进、精密驱动工具（例如手持式微创手术器械）的需求，这些工具在执行这些手术中发挥关键作用。

根据美国脸部整形与重建外科学会 (AAFPRS) 的数据，2023 年执行的手术总数中 83% 是微创手术。此外，根据卡塔赫纳 ISAPS 世界大会的数据显示，外科手术数量增加了 5.5%，整形外科医师实施的手术数量超过 1,580 万例。过去四年，整体成长了40%。手术和微创手术数量的增加推动了手持式微创手术器械的成长。

较小的切口可降低感染、出血和疤痕的风险。这对于喜欢手术后併发症最少的患者来说尤其有吸引力。例如，《柳叶刀》发表的一项研究发现，与接受传统开腹手术的患者相比，接受腹腔镜手术的患者出现的併发症减少了 50%。

仪器和技术成本高

仪器和技术的高成本严重阻碍了手持式微创手术器械市场的成长，预计将阻碍预测期内的市场成长。虽然微创手术具有许多优势，例如缩短恢復时间、减少併发症和提高患者满意度，但先进手术工具和技术的相关成本可能是一个障碍，特别是对于低收入地区或低收入地区的医疗保健系统、医院和病人而言。

微创手术中使用的许多手持式器械，例如腹腔镜剪刀、内视镜钳和机器人辅助工具，前期成本很高。这些工具通常采用先进材料、精密工程和专业功能，所有这些都导致了它们的高价格。例如，根据 ScienceDirect 的数据，将 HandX 与达文西进行比较时，一般外科手持机器人设备的直接仪器成本分别为 310 美元和 973 美元。

许多手持式仪器与成像技术一起使用，例如提供即时可视化的腹腔镜和内视镜。虽然这些技术提高了手术精度，但成本也很高。例如，高清内视镜系统的成本可能在 25,000 美元到 50,000 美元之间，而整合 3D 成像或即时资料处理的先进系统可能会使成本更高。

Handheld minimally invasive surgical instruments refer to a category of surgical tools designed for use in minimally invasive surgical procedures, where smaller incisions are made in the body compared to traditional open surgery. These instruments are specifically designed to facilitate precise, controlled and efficient surgery with minimal trauma to surrounding tissues, leading to faster recovery times, reduced risk of infection and less scarring for patients. These instruments are typically smaller, lighter and more ergonomically designed than traditional surgical tools. Their compact size allows them to fit through smaller incisions, often as small as a few millimeters, without causing significant damage to the surrounding tissues.

The handheld minimally invasive surgical instruments market is experiencing robust growth, fueled by advancements in surgical technology, an increasing preference for minimally invasive procedures, and patient-centered care. With the rising number of surgeries, the demand for these instruments is expected to continue to rise globally. For instance, according to the Government of Saskatchewan, more than 95,700 surgeries were performed between April 1, 2023, and March 31, 2024, the highest annual surgical volume ever recorded.

Market Dynamics: Drivers & Restraints

Increasing demand for minimally invasive surgeries

Increasing demand for minimally invasive surgeries is significantly driving the growth of the handheld minimally invasive surgical instruments market and is expected to drive the market over the forecast period. Minimally invasive surgery, characterized by smaller incisions, reduced blood loss, faster recovery and fewer complications, is gaining widespread adoption among both patients and healthcare providers. This shift in surgical practices is increasing the demand for advanced, precision-driven tools such as handheld minimally invasive surgical instruments, which play a critical role in performing these procedures.

According to the American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS), 83 percent of the total number of procedures performed in 2023 were minimally invasive. Additionally, according to the procedures at the ISAPS World Congress in Cartagena, there is a higher increase of 5.5% in surgical procedures, with more than 15.8 million procedures performed by plastic surgeons. Over the last four years, the overall increase is 40%. This increasing number of surgeries and minimally invasive surgeries driving the growth of handheld minimally invasive surgical instruments.

Smaller incisions reduce the risk of infection, bleeding, and scarring. This is particularly attractive to patients who prefer procedures with minimal post-surgical complications. For instance, a study published in by Lancet found that patients who underwent laparoscopic surgery experienced 50% fewer complications compared to those who had traditional open surgery.

High cost of instruments and technologies

The high cost of instruments and technologies is significantly hampering the growth of the handheld minimally invasive surgical instruments market and is expected to hamper the market growth over the forecast period. While minimally invasive surgeries offer numerous advantages, such as reduced recovery times, fewer complications and enhanced patient satisfaction, the associated costs of advanced surgical tools and technologies can be a barrier, particularly for healthcare systems, hospitals and patients in lower-income regions or those with budget constraints.

Many handheld instruments used in minimally invasive procedures, such as laparoscopic scissors, endoscopic forceps and robotic-assisted tools, come with high upfront costs. These tools often feature advanced materials, precision engineering and specialized functionalities, all of which contribute to their high price. For instance, according to ScienceDirect, direct instrument costs for handheld robotic devices in general surgery were $310 vs $973 when comparing HandX with the DaVinci, respectively.

Many handheld instruments are used alongside imaging technologies, such as laparoscopes and endoscopes which provide real-time visualization. While these technologies improve surgical precision, they also come with high costs. For instance, a high-definition endoscopic system can cost between $25,000 and $50,000, while advanced systems integrated with 3D imaging or real-time data processing can push costs even higher.

Segment Analysis

The global handheld minimally invasive surgical instruments market is segmented based on product type, application, end-user and region.

Application:

The laparoscopy segment is expected to dominate the global handheld minimally invasive surgical instruments market share

The laparoscopy segment holds a major portion of the handheld minimally invasive surgical instruments market share and is expected to continue to hold a significant portion of the market share over the forecast period. This surgical technique, which uses small incisions and specialized tools to perform surgeries, has seen widespread adoption in a variety of medical fields due to its numerous advantages.

For instance, the Lancet study included 97,234 surgical procedures across 676 public hospitals. In total, 16,061 (16.5%) were performed using laparoscopic approaches, which were less common across all procedure categories. The growing preference for laparoscopic surgery is driving the demand for handheld instruments specifically designed for these procedures, which is a major factor contributing to its dominance.

Laparoscopy has become the gold standard for many types of minimally invasive surgeries because it offers faster recovery times, less postoperative pain and smaller scars. These advantages are particularly appealing to patients, leading to the growing preference for laparoscopic techniques. For instance, HandX is a lightweight, FDA-cleared and CE-marked device that combines the benefits of robotics and handheld instruments. HandX allows the surgeon to perform complex minimally invasive surgeries using a device that combines the benefits of a surgical robotic-based platform with the simplicity and affordability of traditional laparoscopic surgery.

Geographical Analysis

North America is expected to hold a significant position in the global handheld minimally invasive surgical instruments market

North America region is expected to hold the largest share in the handheld minimally invasive surgical instruments market over the forecast period. Hospitals and surgical centers in North America, especially in the United States are among the most advanced globally, with a high penetration of minimally invasive surgery tools, including laparoscopic and robotic-assisted instruments.

For instance, in the United States, major hospitals like the Cleveland Clinic and Mayo Clinic are recognized globally for their adoption of robot-assisted and laparoscopic surgeries, which require a wide range of handheld minimally invasive surgical instruments.

Specialized centers for procedures such as cardiac surgery, bariatric surgery, orthopedic surgery and gastrointestinal surgeries often use advanced handheld minimally invasive instruments, further driving demand in the region. A report by IBISWorld indicated that the U.S. healthcare sector was valued at approximately $4.8 trillion in 2023, with a significant portion allocated to surgical services and procedures that use minimally invasive techniques.

Asia Pacific is growing at the fastest pace in the Handheld Minimally Invasive Surgical Instruments market

The Asia Pacific region is experiencing the fastest growth in the handheld minimally invasive surgical instruments market. Many countries in the Asia-Pacific, particularly China, India and Japan, are significantly improving their healthcare infrastructure and investing in modern medical technologies. This is facilitating the adoption of advanced surgical techniques, including minimally invasive surgeries, which require handheld instruments.

As healthcare costs rise and patients seek faster recovery times with fewer complications, there is a strong demand for minimally invasive surgeries in Asia Pacific. Patients in countries like Japan, South Korea and India are increasingly opting for these procedures due to their benefits, such as shorter hospital stays, less postoperative pain and smaller scars. For instance, according to the NIH, more than 570 da Vinci (uses hand-held, long-shafted instruments) units were operational in Japan in 2023, highlighting the growing acceptance of robotic surgery despite the challenges.

Competitive Landscape

The major global players in the handheld minimally invasive surgical instruments market include Medtronic plc, Olympus Corporation, Stryker Corporation, Meril Life Sciences Pvt. Ltd., Boston Scientific Corporation, Wexler Surgical, CONMED Corporation, Smith+Nephew, CooperSurgical Inc., Johnson & Johnson and among others.

Why Purchase the Report?

Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
Post-market Surveillance: Uses post-market data to enhance product safety and access.
Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global handheld minimally invasive surgical instruments market report would provide approximately 62 tables, 57 figures and 197 pages.

Target Audience 2023

Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
Supply Chain: Distribution and Supply Chain Managers.
Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
Academic & Research: Academic Institutions.

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product Type
3.2. Snippet by Application
3.3. Snippet by End-User
3.4. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Increasing Demand for Minimally Invasive Surgeries
  - 4.1.1.2. Technological Advancements in Surgical Tools
- 4.1.2. Restraints
  - 4.1.2.1. High Cost of Instruments and Technologies
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Patent Analysis
5.5. Regulatory Analysis
5.6. SWOT Analysis
5.7. Unmet Needs

6. By Product Type

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 6.1.2. Market Attractiveness Index, By Product Type
6.2. Graspers and Forceps*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Needle Holders
6.4. Scalpels and Dissection Instruments
6.5. Retractors
6.6. Scissors
6.7. Others

7. By Application

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 7.1.2. Market Attractiveness Index, By Application
7.2. Laparoscopy*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Arthroscopy
7.4. Endoscopy
7.5. Others

8. By End-User

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 8.1.2. Market Attractiveness Index, By End-User
8.2. Hospitals*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Ambulatory Surgical Centers
8.4. Specialty Clinics
8.5. Others

9. By Region

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 9.1.2. Market Attractiveness Index, By Region
9.2. North America
- 9.2.1. Introduction
- 9.2.2. Key Region-Specific Dynamics
- 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.2.6.1. U.S.
  - 9.2.6.2. Canada
  - 9.2.6.3. Mexico
9.3. Europe
- 9.3.1. Introduction
- 9.3.2. Key Region-Specific Dynamics
- 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.3.6.1. Germany
  - 9.3.6.2. U.K.
  - 9.3.6.3. France
  - 9.3.6.4. Spain
  - 9.3.6.5. Italy
  - 9.3.6.6. Rest of Europe
9.4. South America
- 9.4.1. Introduction
- 9.4.2. Key Region-Specific Dynamics
- 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.4.6.1. Brazil
  - 9.4.6.2. Argentina
  - 9.4.6.3. Rest of South America
9.5. Asia-Pacific
- 9.5.1. Introduction
- 9.5.2. Key Region-Specific Dynamics
- 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.5.6.1. China
  - 9.5.6.2. India
  - 9.5.6.3. Japan
  - 9.5.6.4. South Korea
  - 9.5.6.5. Rest of Asia-Pacific
9.6. Middle East and Africa
- 9.6.1. Introduction
- 9.6.2. Key Region-Specific Dynamics
- 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

10. Competitive Landscape

10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis

11. Company Profiles

11.1. Medtronic plc*
- 11.1.1. Company Overview
- 11.1.2. Product Portfolio and Description
- 11.1.3. Financial Overview
- 11.1.4. Key Developments
11.2. Olympus Corporation
11.3. Stryker Corporation
11.4. Meril Life Sciences Pvt. Ltd.
11.5. Boston Scientific Corporation
11.6. Wexler Surgical
11.7. CONMED Corporation
11.8. Smith+Nephew
11.9. CooperSurgical Inc.
11.10. Johnson & Johnson

LIST NOT EXHAUSTIVE